Citius Oncology, Inc.
CTOR
Revenue
0.00
0.000.00%
-Assets
49.19M
▲514.37k▲1.06%
3 Months ChangeLiabilities
52.23M
▲1.10M▲2.15%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-13
Form 8-K
ID: 0001213900-24-078287
2024-09-05
Form 8-K
ID: 0001213900-24-076111
2024-08-16
Form 8-K
ID: 0001213900-24-070335
2024-08-09
Form 10-Q
ID: 0001493152-24-030991
2024-08-05
Form 8-K
ID: 0001493152-24-030145
2024-07-19
Form 8-K
ID: 0001493152-24-028500
2024-06-18
Form 8-K
ID: 0001493152-24-024236
2024-06-06
Form 8-K
ID: 0001493152-24-022977
2024-05-21
Form 8-K
ID: 0001493152-24-020866
2024-05-20
Form 10-Q
ID: 0001493152-24-020783